PC-SPES: Current evidence and remaining questions

被引：5

作者：

Ades, T ^{[1
]}

Gansler, T

Miller, M

Rosenthal, DS

机构：

[1] Amer Canc Soc, Atlanta, GA 30329 USA

[2] Harvard Univ, Harvard Univ Hlth Serv, Cambridge, MA 02138 USA

[3] Dana Farber Canc Inst, Zakim Ctr Integrated Therapies, Cambridge, MA USA

来源：

关键词：

D O I：

10.3322/canjclin.51.3.199

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：199 / 204

页数：6

共 50 条

[1] PC-SPES
Ko, R
Wilson, RD
Loscutoff, S
UROLOGY, 2003, 61 (06) : 1292 - 1292
[2] PC-SPES and prostate cancer
Geliebter, J
Mittelman, A
Tiwari, RK
JOURNAL OF NUTRITION, 2001, 131 (01): : 164S - 166S
[3] PC-SPES: Hope or hype?
Kosty, MP
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) : 3657 - 3659
[4] PC-SPES withdrawal response
Chaudhary, UB
Rashid, M
Keane, TE
ACTA ONCOLOGICA, 2004, 43 (08) : 772 - 773
[5] PC-SPES in prostate cancer
Geliebter, J
Tiwari, R
Wu, JM
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (07): : 567 - 567
[6] PC-SPES and prostate cancer
Oh, WK
Small, EJ
UROLOGIC CLINICS OF NORTH AMERICA, 2002, 29 (01) : 59 - +
[7] Contamination of PC-SPES remains a mystery
Reynolds, T
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (17) : 1266 - 1268
[8] Does PC-SPES interact with warfarin?
Davis, NB
Nahlik, L
Vogelzang, NJ
JOURNAL OF UROLOGY, 2002, 167 (04): : 1793 - 1793
[9] PC-SPES: phytotherapy for prostate cancer
Pandha, HS
Kirby, RS
LANCET, 2002, 359 (9325): : 2213 - 2215
[10] PC-Spes rears its head again!
Olsson C.
Current Urology Reports, 2004, 5 (3) : 149 - 149